Prior to the development of mifepristone, the FDA-approved abortion pill that is subject to a pending Supreme Court ruling, drug manufacturers like Chichester Chemical Co. sold women fake abortifacients through coded advertising. The company was based in Philadelphia, in present-day Graduate Hospital.